A new Alexa healthcare skill, called the Emmi Care Plan, provides a voice service that allows patients to easily remain in contact with their healthcare providers while recovering at home after being discharged from the hospital. It’s being launched by Wolters Kluwer, Health, a global leader in providing…
Use of electronic cigarettes (e-cigarettes) is associated with an increased risk of respiratory diseases, including chronic obstructive pulmonary disease (COPD), among young adults, irrespective of other tobacco product use, a large U.S.-based study shows. Compared to healthy people, those currently using e-cigarettes, commonly called vaping, had a 43% increased…
Enrollment in a clinical trial evaluating the mechanism of action of RejuvenAir Metered Cryospray, CSA Medical’s investigational approach for the treatment of chronic bronchitis, has already passed the halfway point, the company announced. However, adults ages 40-79 with chronic bronchitis are still being recruited at the University…
Inhibiting a protein called lymphotoxin beta receptor (LTβR) could be an effective therapeutic strategy for chronic obstructive pulmonary disease (COPD), new research suggests. The findings were published in Nature, in the study “Inhibition of LTβR signalling activates WNT-induced regeneration in lung.” COPD is characterized by the…
Royal Philips has launched a non-invasive ventilator, BiPAP A40 EFL, to remotely monitor patients with chronic obstructive pulmonary disease (COPD) and help them to breathe easier. The device is already available in some European countries, and its expansion to the rest of Europe is expected in the next…
A study has found that fast response to noninvasive ventilation (NIV) following acute exacerbation in people with chronic obstructive pulmonary disease (COPD) is associated with NIV success and significantly lower in-hospital mortality. Identified risk factors for…
Health Care Service Corporation (HCSC) has issued a positive coverage policy for Pulmonx’s Zephyr Endobronchial Valve for treating severe emphysema, a form of chronic obstructive pulmonary disease (COPD). HCSC is the largest customer-owned health insurer in the U.S., and the fifth largest insurer…
The U.S. Food and Drug Administration has granted clearance to PulmoScan, a device developed by Cognita Labs that will facilitate at-home testing of lung function. The device could be useful in providing care to people with respiratory conditions such as asthma and chronic obstructive pulmonary disease…
Training in the handling of inhaler devices improved treatment and eased clinical symptoms in older people with chronic obstructive pulmonary disease (COPD), a study found. COPD patients with evidence of cognitive decline also benefitted from the eight-day training course. The study, “Training improves the handling of inhaler devices…
The first participant has been treated in a clinical trial testing CSA Medical’s RejuvenAir System as a potential treatment for people with moderate to severe chronic obstructive pulmonary disease (COPD) with chronic bronchitis. The participant was treated at Temple University Hospital. At present, the multicenter international…
Get regular updates to your inbox.